Richard, Canada

Klaus H Nielsen


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Richland, CA (1999)
  • Ontario, CA (2003)

Company Filing History:

goldMedal2 out of 832,680 
Other
 patents

Years Active: 1999-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Klaus H Nielsen

Introduction

Klaus H Nielsen is an accomplished inventor based in Richard, CA. He holds 2 patents that showcase his contributions to the field of immunoassays. His work focuses on the detection of antibodies to bacterial antigens, which has significant implications for medical diagnostics.

Latest Patents

Nielsen's latest patents include methods for detecting antibodies to bacterial antigens using fluorescence polarization. In a homogeneous immunoassay, fluorophore-conjugated lipopolysaccharide derived bacterial antigens are reacted with antibodies specific for the antigens. Quantitative detection of the formation of an immune complex is achieved by measuring the change in fluorescence polarization after complex formation. This reaction occurs quickly, taking less than two minutes to reach equilibrium, and involves the addition of only one reagent to a diluted serum specimen. The absence of a solid phase separation step eliminates false positive results and increases throughput.

Career Highlights

Throughout his career, Klaus H Nielsen has made significant advancements in the field of immunoassays. His innovative approaches have improved the efficiency and accuracy of antibody detection, which is crucial for diagnosing bacterial infections.

Collaborations

Nielsen has collaborated with various professionals in his field, including his coworker Michael E Jolley. Their combined expertise has contributed to the development of effective diagnostic methods.

Conclusion

Klaus H Nielsen's work in the field of immunoassays demonstrates his commitment to advancing medical diagnostics. His patents reflect innovative solutions that enhance the detection of bacterial antigens, ultimately benefiting healthcare practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…